Smith TJ - Search Results

1

Integration of Palliative Care Into Standard Oncology Care: American Society of Clinical Oncology Clinical Practice Guideline Update.

Ferrell BR, Temel JS, Temin S, Alesi ER, Balboni TA, Basch EM, Firn JI, Paice JA, Peppercorn JM, Phillips T, Stovall EL, Zimmermann C, Smith TJ. Ferrell BR, et al. Among authors: smith tj. J Clin Oncol. 2017 Jan;35(1):96-112. doi: 10.1200/JCO.2016.70.1474. Epub 2016 Oct 28. J Clin Oncol. 2017. PMID: 28034065 Review.

2

The optimal timing of autologous bone marrow transplantation in Hodgkin's disease patients after a chemotherapy relapse.

Desch CE, Lasala MR, Smith TJ, Hillner BE. Desch CE, et al. Among authors: smith tj. J Clin Oncol. 1992 Feb;10(2):200-9. doi: 10.1200/JCO.1992.10.2.200. J Clin Oncol. 1992. PMID: 1531067

3

Economic evaluation of a randomized clinical trial comparing vinorelbine, vinorelbine plus cisplatin, and vindesine plus cisplatin for non-small-cell lung cancer.

Smith TJ, Hillner BE, Neighbors DM, McSorley PA, Le Chevalier T. Smith TJ, et al. J Clin Oncol. 1995 Sep;13(9):2166-73. doi: 10.1200/JCO.1995.13.9.2166. J Clin Oncol. 1995. PMID: 7666075 Clinical Trial.

4

Ethical considerations in oncology: balancing the interests of patients, oncologists, and society.

Smith TJ, Bodurtha JN. Smith TJ, et al. J Clin Oncol. 1995 Sep;13(9):2464-70. doi: 10.1200/JCO.1995.13.9.2464. J Clin Oncol. 1995. PMID: 7666106

5

Should the elderly receive chemotherapy for node-negative breast cancer? A cost-effectiveness analysis examining total and active life-expectancy outcomes.

Desch CE, Hillner BE, Smith TJ, Retchin SM. Desch CE, et al. Among authors: smith tj. J Clin Oncol. 1993 Apr;11(4):777-82. doi: 10.1200/JCO.1993.11.4.777. J Clin Oncol. 1993. PMID: 8478671

6

Use of hematopoietic colony-stimulating factors: the American Society of Clinical Oncology survey. The Health Services Research Committee of the American Society of Clinical Oncology.

Bennett CL, Smith TJ, Weeks JC, Bredt AB, Feinglass J, Fetting JH, Hillner BE, Somerfield MR, Winn RJ. Bennett CL, et al. Among authors: smith tj. J Clin Oncol. 1996 Sep;14(9):2511-20. doi: 10.1200/JCO.1996.14.9.2511. J Clin Oncol. 1996. PMID: 8823330

7

Economic analysis of adjuvant interferon alfa-2b in high-risk melanoma based on projections from Eastern Cooperative Oncology Group 1684.

Hillner BE, Kirkwood JM, Atkins MB, Johnson ER, Smith TJ. Hillner BE, et al. Among authors: smith tj. J Clin Oncol. 1997 Jun;15(6):2351-8. doi: 10.1200/JCO.1997.15.6.2351. J Clin Oncol. 1997. PMID: 9196150

8

Costs of care associated with non-small-cell lung cancer in a commercially insured cohort.

Hillner BE, McDonald MK, Desch CE, Smith TJ, Penberthy LT, Maddox P, Retchin SM. Hillner BE, et al. Among authors: smith tj. J Clin Oncol. 1998 Apr;16(4):1420-4. doi: 10.1200/JCO.1998.16.4.1420. J Clin Oncol. 1998. PMID: 9552046

9

Economic evaluation of chemotherapy with mitoxantrone plus prednisone for symptomatic hormone-resistant prostate cancer: based on a Canadian randomized trial with palliative end points.

Bloomfield DJ, Krahn MD, Neogi T, Panzarella T, Smith TJ, Warde P, Willan AR, Ernst S, Moore MJ, Neville A, Tannock IF. Bloomfield DJ, et al. Among authors: smith tj. J Clin Oncol. 1998 Jun;16(6):2272-9. doi: 10.1200/JCO.1998.16.6.2272. J Clin Oncol. 1998. PMID: 9626231 Clinical Trial.

10

American Society of Clinical Oncology 1998 update of recommended breast cancer surveillance guidelines.

Smith TJ, Davidson NE, Schapira DV, Grunfeld E, Muss HB, Vogel VG 3rd, Somerfield MR. Smith TJ, et al. J Clin Oncol. 1999 Mar;17(3):1080-2. doi: 10.1200/JCO.1999.17.3.1080. J Clin Oncol. 1999. PMID: 10071303

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,764 results

Search Page

Filters